Skip to main
TFX

Teleflex (TFX) Stock Forecast & Price Target

Teleflex (TFX) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 43%
Sell 0%
Strong Sell 0%

Bulls say

Teleflex is a global medical technology company with high growth potential due to its diversified portfolio of critical care and surgical products. Although the company's recent earnings were positive and future growth is anticipated, potential risks remain. With an "Outperform" rating and a price target of $155, analysts expect strong earnings of $40932736 in 2027 and commend the company for its commitment to sustainability in its operations.

Bears say

Teleflex is facing some challenges in the near term, including sales force realignments and supplier recalls. However, with a new CEO bringing proven MedTech leadership and advancements in its Freesolve pipeline, the company is well-positioned for growth in the long term. The planned divestitures and separation into two publicly traded companies also have the potential to drive shareholder value. Risks include slower growth and margin improvements, as well as the potential for dilutive acquisitions.

Teleflex (TFX) has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 43% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teleflex (TFX) Forecast

Analysts have given Teleflex (TFX) a Buy based on their latest research and market trends.

According to 7 analysts, Teleflex (TFX) has a Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $143.71, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $143.71, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teleflex (TFX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.